Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | ELV | COR | ICLR | AVTR |
| Company | Charles River Laboratories Intl | Elevance Health Inc | Cencora Inc | Icon Plc | Avantor Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NASDAQ | NYSE |
| Open | 227.39 | 536.42 | 240.04 | 302.85 | 23.91 |
| High | 230.86 | 540.00 | 241.36 | 310.41 | 24.44 |
| Low | 227.39 | 529.98 | 238.10 | 300.25 | 23.40 |
| Last | 229.03 | 537.26 | 240.88 | 308.31 | 23.94 |
| Change | +1.22 | -2.42 | +1.12 | +8.23 | -1.21 |
| % Change | +0.54% | -0.45% | +0.47% | +2.74% | -4.81% |
| Volume | 322,100 | 700,700 | 972,700 | 715,400 | 14,185,100 |
| 20-Day Average Volume | 502,320 | 1,170,180 | 1,087,885 | 555,895 | 4,854,440 |
| Previous Close | 227.81 | 539.68 | 239.76 | 300.08 | 25.15 |
| Industry | Medical Services | Medical Services | Medical Services | Medical Services | Medical Services |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 243.13 | 515.36 | 239.21 | 308.30 | 25.04 |
| 20-Day Raw Stochastic | 11.12% | 90.07% | 57.01% | 40.97% | 19.93% |
| 20-Day Relative Strength | 39.43% | 64.17% | 56.14% | 49.28% | 43.15% |
| Weighted Alpha | +17.93 | +19.83 | +44.56 | +53.00 | +22.39 |
| Today's Opinion | 24% Buy | 100% Buy | 88% Buy | 56% Buy | 40% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 88% Buy | 40% Buy | 96% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.99% since 04/19/24 | +1.10% since 04/19/24 | +0.73% since 04/19/24 | +6.97% since 04/19/24 | -0.66% since 04/19/24 |
| Low | 225.79 on 04/22/24 | 527.05 on 04/24/24 | 234.73 on 04/22/24 | 288.23 on 04/22/24 | 23.40 on 04/26/24 |
| High | 244.56 on 04/24/24 | 542.07 on 04/25/24 | 241.36 on 04/26/24 | 318.55 on 04/25/24 | 25.99 on 04/24/24 |
| 1-Month | |||||
| %Chg | -13.72% since 03/26/24 | +3.87% since 03/26/24 | -0.79% since 03/26/24 | -6.55% since 03/26/24 | -5.67% since 03/26/24 |
| Low | 223.49 on 04/18/24 | 493.64 on 04/02/24 | 233.10 on 04/12/24 | 287.02 on 04/19/24 | 23.40 on 04/26/24 |
| High | 273.32 on 04/01/24 | 542.07 on 04/25/24 | 246.75 on 04/03/24 | 338.98 on 04/01/24 | 26.11 on 04/09/24 |
| 3-Month | |||||
| %Chg | +3.97% since 01/26/24 | +11.05% since 01/26/24 | +10.66% since 01/26/24 | +15.68% since 01/26/24 | +5.65% since 01/26/24 |
| Low | 212.52 on 02/01/24 | 480.93 on 01/29/24 | 216.81 on 01/29/24 | 254.60 on 01/31/24 | 21.68 on 02/13/24 |
| High | 275.00 on 03/08/24 | 542.07 on 04/25/24 | 246.75 on 04/03/24 | 344.77 on 03/06/24 | 26.16 on 03/25/24 |
| 6-Month | |||||
| %Chg | +30.82% since 10/26/23 | +19.45% since 10/26/23 | +27.72% since 10/26/23 | +28.16% since 10/26/23 | +22.64% since 10/26/23 |
| Low | 161.65 on 11/01/23 | 437.42 on 11/02/23 | 182.75 on 10/31/23 | 228.05 on 10/30/23 | 16.63 on 10/30/23 |
| High | 275.00 on 03/08/24 | 542.07 on 04/25/24 | 246.75 on 04/03/24 | 344.77 on 03/06/24 | 26.16 on 03/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,797,565 | 124,868,888 | 48,051,224 | 25,434,036 | 16,238,048 |
| Shares Outstanding, K | 51,511 | 232,418 | 199,482 | 82,495 | 678,281 |
| Annual Sales | 4,129,410,000 | 171,340,000,000 | 262,173,410,000 | 8,120,180,000 | 6,967,200,000 |
| Annual Net Income | 474,620,000 | 5,987,000,000 | 1,745,290,000 | 612,340,000 | 321,100,000 |
| Last Quarter Sales | 1,013,480,000 | 42,577,000,000 | 72,252,840,000 | 2,066,250,000 | 1,722,800,000 |
| Last Quarter Net Income | 187,080,000 | 2,246,000,000 | 601,500,000 | 216,420,000 | 98,500,000 |
| 60-Month Beta | 1.40 | 0.78 | 0.45 | 1.15 | 1.37 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.46 on 02/14/24 | 10.64 on 04/18/24 | 3.28 on 01/31/24 | 3.47 on 04/24/24 | 0.22 on 04/26/24 |
| Latest Earnings Date | 05/09/24 | 04/18/24 | 05/01/24 | 04/24/24 | 04/26/24 |
| Most Recent Dividend | N/A | 1.630 on 03/07/24 | 0.510 on 02/08/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 06/10/24 | 02/08/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 21.39 | 15.74 | 19.09 | 23.37 | 23.50 |